Amicus Therapeutics Inc. buy Cantor Fitzgerald
Start price
29.02.24
/
50%
€11.80
Target price
28.02.25
€20.36
Performance (%)
-17.80%
Price
20.09.24
€9.70
Summary
This prediction is currently active. The prediction for Amicus Therapeutics Inc. disappoints with a performance of -17.80%. This prediction currently runs until 28.02.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amicus Therapeutics Inc. | -4.902% | -4.902% |
iShares Core DAX® | 0.347% | 2.173% |
iShares Nasdaq 100 | 0.715% | 0.138% |
iShares Nikkei 225® | 1.522% | 2.003% |
iShares S&P 500 | 0.631% | 1.633% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $22.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.00
20.09.24
20.09.24
€17.90
20.09.25
20.09.25
0.00%
20.09.24
20.09.24